[ad_1]
Health-care firms ticked up as merchants guess the sector would profit from merger exercise and earnings progress.
One analysis agency mentioned the variety of bets in opposition to health-care shares has shrunk just lately.
“Short sellers steadily reduced their bets against healthcare stocks in 2022, ending November with the lowest level of short interest in the sector in more than a year,” mentioned analysts at analysis agency S&P Global.
Bets in opposition to biotechnology shares stay some of the common short-selling methods, nonetheless, in line with S&P’s analysis.
Write to Rob Curran at rob.curran@dowjones.com
[adinserter block=”4″]
[ad_2]
Source link